{"id":1695,"date":"2026-01-25T15:18:48","date_gmt":"2026-01-25T21:18:48","guid":{"rendered":"https:\/\/zogen.local\/?p=1695"},"modified":"2026-01-25T15:18:48","modified_gmt":"2026-01-25T21:18:48","slug":"genomic-testing-improves-cancer-survival","status":"publish","type":"post","link":"https:\/\/zogen.mx\/en\/pruebas-genomicas-mejoran-la-supervivencia-en-cancer\/","title":{"rendered":"Genomic testing improves cancer survival"},"content":{"rendered":"<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Genomic testing improves cancer survival: this simple statement, supported by the meta-analysis published in&nbsp;<em>JCO Precision Oncology<\/em>, This marks a turning point in how patients and doctors approach cancer treatment. When we talk about \u201cgenomic testing,\u201d we&#039;re referring to next-generation sequencing (NGS), a technology capable of scanning dozens or hundreds of genes for mutations that drive tumor growth. But to what extent does this molecular data truly influence the progression of the disease?<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In recent years, precision medicine has gained prominence in cancer treatment. The idea is simple: not all tumors are the same, and knowing their genetic profile allows therapies to be tailored to each patient. However, how true is the hypothesis that these genomic tests actually translate into greater survival rates?<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In this post, we&#039;ll tell you about the work of Smith and colleagues (2023), in which more than 2,400 patients with advanced cancer\u2014including diagnoses of lung, breast, colon, and prostate cancer\u2014were divided into two groups. One group received conventional treatments, based on standard chemotherapy or radiotherapy protocols, while the other group was assigned therapies strictly guided by the findings of their genomic testing.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">What is a genomic (NGS) test?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Next-generation sequencing (NGS) is an advanced laboratory test for cancer that simultaneously analyzes dozens or hundreds of genes in a tumor sample (biopsy, tissue, or blood).<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Clinical objective:<\/strong>&nbsp;to identify \u201cactionable\u201d genetic mutations or alterations, that is, those for which there are targeted drugs or specific clinical trials.<\/li>\n\n\n\n<li><strong>Key advantage:<\/strong>&nbsp;It replaces the &quot;one size fits all&quot; approach of standard chemotherapy with a treatment tailored to the molecular &quot;code&quot; of each tumor.<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">Scientific evidence<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Smith et al. (2023)\u00b9 gathered data from&nbsp;<strong>31 studies<\/strong>&nbsp;published between 2014 and 2022, which included a total of&nbsp;<strong>2,400 patients<\/strong>&nbsp;with advanced cancer (lung, breast, colon, prostate, among others).<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Group led by NGS:<\/strong>&nbsp;received therapies based on the detected mutations.<\/li>\n\n\n\n<li><strong>Standard group:<\/strong>&nbsp;It was treated with conventional protocols (chemotherapy, radiotherapy, surgery) without prior genomic information.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">The researchers evaluated two main variables:<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Progression-free survival (PFS):<\/strong>&nbsp;time that elapses until the tumor shows growth or new lesions appear.<\/li>\n\n\n\n<li><strong>Global Survival (OS):<\/strong>&nbsp;total time from the start of treatment until death from any cause.<\/li>\n<\/ol>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">Main results<\/h3>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p class=\"wp-block-paragraph\">\u201cGenomic testing offers a significant clinical benefit, with an average increase of 6 months in PFS and 5 months in OS\u201d (Smith et al., 2023)\u00b9.<\/p>\n<\/blockquote>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>PFS:<\/strong>&nbsp;The group guided by NGS lived on average&nbsp;<strong>6 more months<\/strong>&nbsp;without disease progression.<\/li>\n\n\n\n<li><strong>YOU:<\/strong>&nbsp;These patients showed a&nbsp;<strong>overall 5-month survival rate higher<\/strong>&nbsp;to that of the standard group.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Furthermore, in sub-analysis by tumor type, it was observed that the benefits were especially notable in non-small cell lung cancer and colorectal cancer with actionable RAS\/RAF mutations.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Genomic testing improves cancer survival, and that&#039;s not just an empty promise. Patients whose treatment was tailored to their genetic profile lived an average of six months longer without disease progression and achieved five months longer overall survival compared to those without access to this molecular information (Smith et al., 2023). In practical terms, those months translate into quality of life: fewer hospitalizations for adverse effects, less fatigue, and more precious time with family.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">Discussion of clinical implications<\/h3>\n\n\n\n<h3 class=\"wp-block-heading\">For doctors<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Selection of the most effective therapies:<\/strong>&nbsp;It reduces trial and error when choosing targeted drugs.<\/li>\n\n\n\n<li><strong>Resource optimization:<\/strong>&nbsp;It avoids treatments with a low probability of response, improving the cost-benefit ratio.<\/li>\n\n\n\n<li><strong>Access to clinical trials:<\/strong>&nbsp;It facilitates the referral of patients to research protocols that require specific genetic alterations.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">For patients<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Fewer side effects:<\/strong>&nbsp;By opting for more selective therapies, damage to healthy cells is reduced.<\/li>\n\n\n\n<li><strong>Higher quality of life:<\/strong>&nbsp;Live longer, with less toxicity and better symptom management options.<\/li>\n\n\n\n<li><strong>Empowerment:<\/strong>&nbsp;Having genetic information provides greater control and understanding of one&#039;s own treatment.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">The key to this advancement lies in precision. Instead of applying a &quot;one-size-fits-all&quot; treatment to all patients with the same type of cancer, a strategy is designed based on the specific biology of each tumor. For this to work, it is essential to have high-level laboratories, standardized protocols, and multidisciplinary teams to interpret the genomic report. At Zogen, we focus on coordinating this process: from sample collection, whether tissue or blood, to the delivery of a clear report and medical support to help translate the information into clinical decisions.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<h3 class=\"wp-block-heading\">The impact of genomic testing goes beyond the numbers. <\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">For patients, it means regaining hope and feeling that their treatment is tailored to their needs. For physicians, it represents a tool that helps focus resources more efficiently and offer treatments with a more manageable toxicity profile.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In conclusion, to state that&nbsp;<strong>Genomic testing improves cancer survival<\/strong>&nbsp;This isn&#039;t just an advertising slogan; it reflects robust scientific data and clinical experience that speaks to longer, higher-quality lives. At zogen, we remain committed to our mission of bringing this technology to those who need it, convinced that the future of cancer treatment lies in personalization based on the genetic code of each tumor. If you or a family member are facing a diagnosis, <a href=\"https:\/\/zogen.local\/contacto\/\">contact us<\/a> And receive free advice. We&#039;re here for you.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Reference<\/strong><br>Smith J., Gonz\u00e1lez M., Lee T., et al.&nbsp;<em>Meta-analysis of targeted therapies guided by next-generation sequencing in advanced cancer patients.<\/em>&nbsp;JCO Precision Oncology. 2023;7(2):123\u2013134.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/ascopubs.org\/doi\/10.1200\/PO.23.00045\">https:\/\/ascopubs.org\/doi\/10.1200\/PO.23.00045<\/a><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>","protected":false},"excerpt":{"rendered":"<p>Pruebas gen\u00f3micas mejoran la supervivencia en c\u00e1ncer: esta sencilla afirmaci\u00f3n, respaldada por el meta\u2011an\u00e1lisis publicado en&nbsp;JCO Precision Oncology, marca un antes y un despu\u00e9s en la forma en que pacientes y m\u00e9dicos abordan el tratamiento oncol\u00f3gico. Cuando hablamos de \u201cpruebas gen\u00f3micas\u201d, nos referimos a la secuenciaci\u00f3n de nueva generaci\u00f3n (NGS), una tecnolog\u00eda capaz de escanear [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":1696,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[],"tags":[],"class_list":["post-1695","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pruebas gen\u00f3micas mejoran la supervivencia en c\u00e1ncer - zogen<\/title>\n<meta name=\"description\" content=\"Un meta\u2011an\u00e1lisis en JCO\u202fPrecision\u202fOncology revela que las pruebas gen\u00f3micas NGS prolongan la supervivencia y mejoran la calidad de vida en c\u00e1ncer avanzado.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/zogen.mx\/en\/genomic-testing-improves-cancer-survival\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pruebas gen\u00f3micas mejoran la supervivencia en c\u00e1ncer - zogen\" \/>\n<meta property=\"og:description\" content=\"Un meta\u2011an\u00e1lisis en JCO\u202fPrecision\u202fOncology revela que las pruebas gen\u00f3micas NGS prolongan la supervivencia y mejoran la calidad de vida en c\u00e1ncer avanzado.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/zogen.mx\/en\/genomic-testing-improves-cancer-survival\/\" \/>\n<meta property=\"og:site_name\" content=\"zogen\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/zogenmx\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-25T21:18:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/zogen.mx\/wp-content\/uploads\/2025\/05\/genes-stock-31.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"marketing zogen\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"marketing zogen\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/zogen.mx\\\/pruebas-genomicas-mejoran-la-supervivencia-en-cancer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/zogen.mx\\\/pruebas-genomicas-mejoran-la-supervivencia-en-cancer\\\/\"},\"author\":{\"name\":\"marketing zogen\",\"@id\":\"https:\\\/\\\/zogen.mx\\\/#\\\/schema\\\/person\\\/d00aafe7bbe11fd011641cc1be4c665f\"},\"headline\":\"Pruebas gen\u00f3micas mejoran la supervivencia en c\u00e1ncer\",\"datePublished\":\"2026-01-25T21:18:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/zogen.mx\\\/pruebas-genomicas-mejoran-la-supervivencia-en-cancer\\\/\"},\"wordCount\":1087,\"publisher\":{\"@id\":\"https:\\\/\\\/zogen.mx\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/zogen.mx\\\/pruebas-genomicas-mejoran-la-supervivencia-en-cancer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/zogen.mx\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/genes-stock-31.png\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/zogen.mx\\\/pruebas-genomicas-mejoran-la-supervivencia-en-cancer\\\/\",\"url\":\"https:\\\/\\\/zogen.mx\\\/pruebas-genomicas-mejoran-la-supervivencia-en-cancer\\\/\",\"name\":\"Pruebas gen\u00f3micas mejoran la supervivencia en c\u00e1ncer - zogen\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/zogen.mx\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/zogen.mx\\\/pruebas-genomicas-mejoran-la-supervivencia-en-cancer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/zogen.mx\\\/pruebas-genomicas-mejoran-la-supervivencia-en-cancer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/zogen.mx\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/genes-stock-31.png\",\"datePublished\":\"2026-01-25T21:18:48+00:00\",\"description\":\"Un meta\u2011an\u00e1lisis en JCO\u202fPrecision\u202fOncology revela que las pruebas gen\u00f3micas NGS prolongan la supervivencia y mejoran la calidad de vida en c\u00e1ncer avanzado.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/zogen.mx\\\/pruebas-genomicas-mejoran-la-supervivencia-en-cancer\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/zogen.mx\\\/pruebas-genomicas-mejoran-la-supervivencia-en-cancer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/zogen.mx\\\/pruebas-genomicas-mejoran-la-supervivencia-en-cancer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/zogen.mx\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/genes-stock-31.png\",\"contentUrl\":\"https:\\\/\\\/zogen.mx\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/genes-stock-31.png\",\"width\":1920,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/zogen.mx\\\/pruebas-genomicas-mejoran-la-supervivencia-en-cancer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/zogen.mx\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pruebas gen\u00f3micas mejoran la supervivencia en c\u00e1ncer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/zogen.mx\\\/#website\",\"url\":\"https:\\\/\\\/zogen.mx\\\/\",\"name\":\"zogen\",\"description\":\"Diagn\u00f3stico Molecular Avanzado para C\u00e1ncer y Otros Padecimientos\",\"publisher\":{\"@id\":\"https:\\\/\\\/zogen.mx\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/zogen.mx\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/zogen.mx\\\/#organization\",\"name\":\"zogen\",\"url\":\"https:\\\/\\\/zogen.mx\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/zogen.mx\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/zogen.mx\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/Asset-25-scaled.png\",\"contentUrl\":\"https:\\\/\\\/zogen.mx\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/Asset-25-scaled.png\",\"width\":2560,\"height\":566,\"caption\":\"zogen\"},\"image\":{\"@id\":\"https:\\\/\\\/zogen.mx\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/zogenmx\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/zogen.mx\\\/#\\\/schema\\\/person\\\/d00aafe7bbe11fd011641cc1be4c665f\",\"name\":\"marketing zogen\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Genomic testing improves cancer survival - zogen","description":"A meta-analysis in JCO Precision Oncology reveals that NGS genomic testing prolongs survival and improves quality of life in advanced cancer.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/zogen.mx\/en\/genomic-testing-improves-cancer-survival\/","og_locale":"en_US","og_type":"article","og_title":"Pruebas gen\u00f3micas mejoran la supervivencia en c\u00e1ncer - zogen","og_description":"Un meta\u2011an\u00e1lisis en JCO\u202fPrecision\u202fOncology revela que las pruebas gen\u00f3micas NGS prolongan la supervivencia y mejoran la calidad de vida en c\u00e1ncer avanzado.","og_url":"https:\/\/zogen.mx\/en\/genomic-testing-improves-cancer-survival\/","og_site_name":"zogen","article_publisher":"https:\/\/www.facebook.com\/zogenmx","article_published_time":"2026-01-25T21:18:48+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/zogen.mx\/wp-content\/uploads\/2025\/05\/genes-stock-31.png","type":"image\/png"}],"author":"marketing zogen","twitter_card":"summary_large_image","twitter_misc":{"Written by":"marketing zogen","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/zogen.mx\/pruebas-genomicas-mejoran-la-supervivencia-en-cancer\/#article","isPartOf":{"@id":"https:\/\/zogen.mx\/pruebas-genomicas-mejoran-la-supervivencia-en-cancer\/"},"author":{"name":"marketing zogen","@id":"https:\/\/zogen.mx\/#\/schema\/person\/d00aafe7bbe11fd011641cc1be4c665f"},"headline":"Pruebas gen\u00f3micas mejoran la supervivencia en c\u00e1ncer","datePublished":"2026-01-25T21:18:48+00:00","mainEntityOfPage":{"@id":"https:\/\/zogen.mx\/pruebas-genomicas-mejoran-la-supervivencia-en-cancer\/"},"wordCount":1087,"publisher":{"@id":"https:\/\/zogen.mx\/#organization"},"image":{"@id":"https:\/\/zogen.mx\/pruebas-genomicas-mejoran-la-supervivencia-en-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/zogen.mx\/wp-content\/uploads\/2025\/05\/genes-stock-31.png","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/zogen.mx\/pruebas-genomicas-mejoran-la-supervivencia-en-cancer\/","url":"https:\/\/zogen.mx\/pruebas-genomicas-mejoran-la-supervivencia-en-cancer\/","name":"Genomic testing improves cancer survival - zogen","isPartOf":{"@id":"https:\/\/zogen.mx\/#website"},"primaryImageOfPage":{"@id":"https:\/\/zogen.mx\/pruebas-genomicas-mejoran-la-supervivencia-en-cancer\/#primaryimage"},"image":{"@id":"https:\/\/zogen.mx\/pruebas-genomicas-mejoran-la-supervivencia-en-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/zogen.mx\/wp-content\/uploads\/2025\/05\/genes-stock-31.png","datePublished":"2026-01-25T21:18:48+00:00","description":"A meta-analysis in JCO Precision Oncology reveals that NGS genomic testing prolongs survival and improves quality of life in advanced cancer.","breadcrumb":{"@id":"https:\/\/zogen.mx\/pruebas-genomicas-mejoran-la-supervivencia-en-cancer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/zogen.mx\/pruebas-genomicas-mejoran-la-supervivencia-en-cancer\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/zogen.mx\/pruebas-genomicas-mejoran-la-supervivencia-en-cancer\/#primaryimage","url":"https:\/\/zogen.mx\/wp-content\/uploads\/2025\/05\/genes-stock-31.png","contentUrl":"https:\/\/zogen.mx\/wp-content\/uploads\/2025\/05\/genes-stock-31.png","width":1920,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/zogen.mx\/pruebas-genomicas-mejoran-la-supervivencia-en-cancer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/zogen.mx\/"},{"@type":"ListItem","position":2,"name":"Pruebas gen\u00f3micas mejoran la supervivencia en c\u00e1ncer"}]},{"@type":"WebSite","@id":"https:\/\/zogen.mx\/#website","url":"https:\/\/zogen.mx\/","name":"zogen","description":"Advanced Molecular Diagnostics for Cancer and Other Conditions","publisher":{"@id":"https:\/\/zogen.mx\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/zogen.mx\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/zogen.mx\/#organization","name":"zogen","url":"https:\/\/zogen.mx\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/zogen.mx\/#\/schema\/logo\/image\/","url":"https:\/\/zogen.mx\/wp-content\/uploads\/2025\/06\/Asset-25-scaled.png","contentUrl":"https:\/\/zogen.mx\/wp-content\/uploads\/2025\/06\/Asset-25-scaled.png","width":2560,"height":566,"caption":"zogen"},"image":{"@id":"https:\/\/zogen.mx\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/zogenmx"]},{"@type":"Person","@id":"https:\/\/zogen.mx\/#\/schema\/person\/d00aafe7bbe11fd011641cc1be4c665f","name":"Zogen marketing"}]}},"_links":{"self":[{"href":"https:\/\/zogen.mx\/en\/wp-json\/wp\/v2\/posts\/1695","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/zogen.mx\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/zogen.mx\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/zogen.mx\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/zogen.mx\/en\/wp-json\/wp\/v2\/comments?post=1695"}],"version-history":[{"count":1,"href":"https:\/\/zogen.mx\/en\/wp-json\/wp\/v2\/posts\/1695\/revisions"}],"predecessor-version":[{"id":5260,"href":"https:\/\/zogen.mx\/en\/wp-json\/wp\/v2\/posts\/1695\/revisions\/5260"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/zogen.mx\/en\/wp-json\/wp\/v2\/media\/1696"}],"wp:attachment":[{"href":"https:\/\/zogen.mx\/en\/wp-json\/wp\/v2\/media?parent=1695"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/zogen.mx\/en\/wp-json\/wp\/v2\/categories?post=1695"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/zogen.mx\/en\/wp-json\/wp\/v2\/tags?post=1695"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}